Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 5/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.36 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL563134 | 1.00 | HPGD (0.41) | HPGDALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL562481 | 0.79 | MAPT (0.38) | — | |
| SCHEMBL563180 | 0.71 | ALDH1A1 (0.45) | HPGDALDH1A1ELANECTSLCTSB | |
| SCHEMBL4254997 | 0.70 | KMT2A (0.59) | HPGDALDH1A1 | |
| SCHEMBL6947425 | 0.70 | KMT2A (0.59) | HPGDALDH1A1 | |
| SCHEMBL6947422 | 0.70 | KMT2A (0.59) | HPGDALDH1A1 | |
| SCHEMBL12819983 | 0.67 | HTR2C (0.43) | HPGDALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL15778380 | 0.67 | ALDH1A1 (0.50) | HPGDALDH1A1CYP2C19TDP1 | |
| SCHEMBL23966960 | 0.66 | BRD4 (0.59) | HPGDALDH1A1ELANEGPBAR1 | |
| SCHEMBL7640383 | 0.66 | ALDH1A1 (0.43) | ALDH1A1CYP3A4CYP2C9CYP2C19CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8420818-B2 | Process for the preparation of pyrido[2,1-a] isoquinoline derivatives | HOFFMANN-LA ROCHE INC. (US) | 2013-04-16 | — | — | US | disclosed |
| EP-2234997-B1 | PROCESS FOR THE PREPARATION OF PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2012-09-05 | — | — | EP | disclosed |
| US-20120035368-A1 | PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES | ABRECHT STEFAN (CH) | 2012-02-09 | — | — | US | disclosed |
| US-20090163718-A1 | PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163718-A1 | PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES | DPP4, DPP7, DPP3 | HPGD 936/4885ALDH1A1 62/4885CYP3A4 8/4885 |
| US-20120035368-A1 | PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES | DPP4, DPP7, DPP3 | HPGD 936/4885ALDH1A1 62/4885CYP3A4 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.